Cover Image
市場調查報告書

美國的注射器及注射針市場未來展望

United States Syringes and Needles Market Outlook to 2021

出版商 GlobalData 商品編碼 358561
出版日期 內容資訊 英文 104 Pages
訂單完成後即時交付
價格
Back to Top
美國的注射器及注射針市場未來展望 United States Syringes and Needles Market Outlook to 2021
出版日期: 2016年03月01日 內容資訊: 英文 104 Pages
簡介

本報告提供美國的注射器及針頭市場相關分析,提供您整體市場趨勢的轉變和預測 (過去·今後8年份),主要企業·流通管道的市場佔有率,主要的開發中產品目前臨床實驗情形,近來的資本交易·企業發展的動向,主要企業簡介等之調查評估。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 注射器及注射針市場明細
  • 本報告分析對像市場定義

第3章 美國的注射器及注射針市場

  • 市場收益額的實際成果值:以金額為準 (過去8年份)
  • 市場收益額的預測值:以金額為準 (今後8年份)
  • 市場規模的實際成果值:以數量為準 (過去8年份)
  • 市場規模的預測值:以數量為準 (今後8年份)
  • 平均價格趨勢·預測 (總計15年份)
  • 市場收益額佔有率:各流通管道
  • 市場收益額佔有率:各企業

第4章 主要企業概要:美國的注射器及注射針市場

  • Becton, Dickinson and Company
  • Braun Melsungen AG
  • Nipro
  • Baxter International Inc.
  • Smiths Medical
  • Covidien plc

第5章 注射器及注射針市場開發中產品

第6章 資本交易趨勢

  • 企業收購 (全2件)
  • 資產交易 (全2件)
  • 股票上市 (1件)
  • 產業聯盟 (1件)
  • 風險企業融資 (全3件)

第7章 近幾年的市場趨勢

  • 企業的發表 (企業·通訊) (全9件)
  • 公佈財報 (全24件)
  • 法規·規定關係 (全8件)
  • 其他主要動向 (全7件)
  • 產品新聞 (全2件)
  • 策略·產業計畫 (全10件)

第8章 附錄

圖表一覽

目錄
Product Code: GDMECC1596DB

GlobalData's new report, "United States Syringes and Needles Market Outlook to 2021", provides key market data on the United States Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Syringes and Needles market segments - General Syringes and Specialized Syringes.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Syringes and Needles market.
  • Global corporate-level profiles of key companies operating within the United States Syringes and Needles market.
  • Key players covered include Becton, Dickinson and Company, Covidien plc, B. Braun Melsungen AG, Nipro Corporation and others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Syringes and Needles Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Syringes and Needles Market, United States

  • 3.1. Syringes and Needles Market, United States, Revenue ($m), 2007-2014
  • 3.2. Syringes and Needles Market, United States, Revenue ($m), 2014-2021
  • 3.3. Syringes and Needles Market, United States, Volume (Units), 2007-2014
  • 3.4. Syringes and Needles Market, United States, Volume (Units), 2014-2021
  • 3.5. Syringes and Needles Market, United States, Average Price ($), 2007-2021
  • 3.6. Syringes and Needles Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Syringes and Needles Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Syringes and Needles Market

  • 4.1. Becton, Dickinson and Company
    • 4.1.1. Company Overview
  • 4.2. B. Braun Melsungen AG
    • 4.2.1. Company Overview
  • 4.3. Nipro Corporation
    • 4.3.1. Company Overview
  • 4.4. Baxter International Inc.
    • 4.4.1. Company Overview
  • 4.5. Smiths Medical
    • 4.5.1. Company Overview
  • 4.6. Covidien plc
    • 4.6.1. Company Overview

5. Syringes and Needles Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Sagent Pharma May Sell Itself
    • 6.1.2. ICU Medical Acquires Excelsior Medical for USD59.5 Million
  • 6.2. Asset Transactions
    • 6.2.1. Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson
    • 6.2.2. Medline Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million
  • 6.3. Equity Offerings
    • 6.3.1. Unilife to Raise USD45 Million in Private Placement of Shares
  • 6.4. Partnerships
    • 6.4.1. Enable Injections Enters into Partnership with Flextronics International
  • 6.5. Venture Financing
    • 6.5.1. PharmaJet Raises USD3.7 Million in Financing Round
    • 6.5.2. PharmaJet Raises Additional USD2.2 Million in Financing Round
    • 6.5.3. EndoChoice Raises USD57 Million in Venture Financing

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences
    • 7.1.2. Aug 25, 2015: Unilife Appoints Harry Hamill to the Board of Directors
    • 7.1.3. Aug 03, 2015: Sagent Pharmaceuticals Board Appoints Allan Oberman as Chief Executive Officer
    • 7.1.4. Aug 01, 2015: SPARC Receives Complete Response Letter from USFDA for Latanoprost NDA
    • 7.1.5. Jun 03, 2015: Bristol-Myers Squibb to Present Data from 14 Abstracts on Orencia (abatacept) at the European League Against Rheumatism (EULAR) 2015 Annual Meeting
    • 7.1.6. Apr 16, 2015: Sagent Pharmaceuticals Appoints Michael Logerfo as President
    • 7.1.7. Apr 16, 2015: Shlomo Yanai Joins Sagent Pharmaceuticals Board of Directors
    • 7.1.8. Apr 08, 2015: Unilife Appoints Dr. Richard Beckman as Chief Medical Officer
    • 7.1.9. Mar 26, 2015: Sagent Pharmaceuticals Announces Leadership Changes
  • 7.2. Financial Announcements
    • 7.2.1. Feb 16, 2016: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results
    • 7.2.2. Feb 09, 2016: Unilife Announces Financial Results For the Second Quarter of Fiscal Year 2016
    • 7.2.3. Feb 03, 2016: BD Announces Results For 2016 First Fiscal Quarter
    • 7.2.4. Nov 09, 2015: Unilife Announces Financial Results For the First Quarter of Fiscal Year 2016
    • 7.2.5. Nov 04, 2015: BD Announces Results For 2015 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2016 Guidance
    • 7.2.6. Oct 13, 2015: Spring Bank Pharmaceuticals Announces Presentation of Results from Phase I Clinical Trial Supporting the Novel Mechanism of Action of SB 9200 in Patients with Hepatitis C at The Liver Meeting
    • 7.2.7. Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015
    • 7.2.8. Sep 14, 2015: Unilife Corporation Announces Financial Results For the Fourth Quarter and Full Fiscal Year 2015
    • 7.2.9. Aug 14, 2015: Retractable Technologies Reports Results as of June 30, 2015
    • 7.2.10. Aug 06, 2015: BD Announces Results for 2015 Third Fiscal Quarter and Raises EPS Guidance for Fiscal 2015
    • 7.2.11. Aug 04, 2015: Sagent Pharmaceuticals Reports Second Quarter 2015 Financial Results
    • 7.2.12. Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results
    • 7.2.13. Jul 28, 2015: Centinel Spine Implants Its First STALIF MIDLINE II-Ti Device
    • 7.2.14. May 15, 2015: Retractable Technologies Reports Improved Results for the First Quarter 2015
    • 7.2.15. May 11, 2015: Unilife Announces Financial Results For Fiscal Year 2015 Third Quarter
    • 7.2.16. May 07, 2015: BD Announces Results For 2015 Second Fiscal Quarter
    • 7.2.17. May 05, 2015: Sagent Pharmaceuticals Reports First Quarter 2015 Financial Results
    • 7.2.18. Apr 28, 2015: Hospira Reports First-Quarter 2015 Results
    • 7.2.19. Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System
    • 7.2.20. Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study
    • 7.2.21. Apr 07, 2015: Dualis MedTech and ReliantHeart Partner on Fully Implantable TET System for the HeartAssist5 LVAD
    • 7.2.22. Apr 01, 2015: Retractable Technologies Reports Results for the Three and Twelve Months Ended December 31, 2014
    • 7.2.23. Mar 02, 2015: Neuren receives FDA response to request for Breakthrough Therapy
    • 7.2.24. Feb 19, 2015: Sagent Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Results
  • 7.3. Legal And Regulatory
    • 7.3.1. Jul 23, 2015: Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials
    • 7.3.2. May 21, 2015: Retractable Technologies Reports Recognition of Payment
    • 7.3.3. May 01, 2015: Hospira Statement On FDA's Final Biosimilar Guidance Documents
    • 7.3.4. Apr 27, 2015: Retractable Technologies Announces Amended Final Judgment and Notice of Appeal
    • 7.3.5. Apr 21, 2015: Retractable Technologies Announces U.S. Supreme Court Decision - Denial of Writ of Certiorari
    • 7.3.6. Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant
    • 7.3.7. Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines
    • 7.3.8. Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India
  • 7.4. Other Significant Developments
    • 7.4.1. Nov 03, 2015: Sigma-Aldrich Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00
    • 7.4.2. Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes
    • 7.4.3. Sep 15, 2015: BD Named 2015 Outstanding Corporate Innovator Winner by Product Development and Management Association
    • 7.4.4. May 07, 2015: Sigma-Aldrich Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend.
    • 7.4.5. May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement
    • 7.4.6. Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche
    • 7.4.7. Mar 19, 2015: Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich
  • 7.5. Product News
    • 7.5.1. Oct 05, 2015: Galil Medical Launches New Family Of Cryoablation Needles
    • 7.5.2. Apr 13, 2015: Cadence Announces New LaserSwiss Capability
  • 7.6. Strategy And Business Planning
    • 7.6.1. Jan 21, 2016: Singularity University and BD Announce Collaboration Dedicated to Address Global Healthcare Challenges
    • 7.6.2. Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems
    • 7.6.3. Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma
    • 7.6.4. Jul 13, 2015: BD Announces Sustainability Goals for 2020
    • 7.6.5. Jul 08, 2015: BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts
    • 7.6.6. May 21, 2015: Cadence Announces Major Expansion of Wisconsin Facility
    • 7.6.7. May 18, 2015: Haselmeier Group Announces the Relocation of Haselmeier in the United States
    • 7.6.8. May 12, 2015: SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling
    • 7.6.9. Apr 17, 2015: Sigma-Aldrich Expands Customer-Centric Model with Investments in Singapore That Localize World-Class Capabilities to Better Support Customers in Asia
    • 7.6.10. Apr 06, 2015: Breakout Labs and Becton, Dickinson and Company Partner to Provide Capital and Expertise to Biomedical Startups

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Company Share Analysis
    • 8.1.5. Distribution Share Analysis
  • 8.2. GlobalData Consulting
  • 8.3. Contact Us
  • 8.4. Disclaimer

List of Tables

  • Table 1: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014
  • Table 4: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 5: Syringes and Needles Market, United States, Average Price ($), Historic, 2007-2014
  • Table 6: Syringes and Needles Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 7: Syringes and Needles Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 8: Syringes and Needles Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Syringes and Needles Market Pipeline Products
  • Table 10: Sagent Pharma May Sell Itself
  • Table 11: ICU Medical Acquires Excelsior Medical for USD59.5 Million
  • Table 12: Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson
  • Table 13: Medline Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million
  • Table 14: Unilife to Raise USD45 Million in Private Placement of Shares
  • Table 15: Enable Injections Enters into Partnership with Flextronics International
  • Table 16: PharmaJet Raises USD3.7 Million in Financing Round
  • Table 17: PharmaJet Raises Additional USD2.2 Million in Financing Round
  • Table 18: EndoChoice Raises USD57 Million in Venture Financing

List of Figures

  • Figure 1: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Syringes and Needles Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Syringes and Needles Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 4: Syringes and Needles Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 5: Syringes and Needles Market, United States, Company Share (%) 2014
Back to Top